Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives

Schizophrenia Bulletin

Volumn 33, Issue 1, 2007, Pages 174-182

  Lin, Sheng Hsiang ^a   Liu, Chih Min ^b,c   Chang, Shu Sen ^a,d   Hwu, Hai Gwo ^a,b   Liu, Shi K ^b,e   Hwang, Tzung J ^b   Hsieh, Ming Hsien ^b   Guo, Shi Chin ^d   Chen, Wei J ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d Ju Shan Hospital   (Taiwan)

^e FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Heritability; Nicotinic acid; Prostaglandin; Recurrence risk ratio; Vulnerability indicator

Indexed keywords

NICOTINIC ACID;

ADULT; AGE DISTRIBUTION; ALLERGY; ARTICLE; COFFEE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG RESPONSE; FAMILIAL DISEASE; FEMALE; FLUSHING; FOREARM; GENETIC ASSOCIATION; HERITABILITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; RECURRENCE RISK; RELATIVE; SAMPLING; SCHIZOPHRENIA; SCORING SYSTEM; SEX RATIO; SKIN; SKIN MANIFESTATION; SMOKING;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUSHING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NIACIN; PHENOTYPE; RISK ASSESSMENT; SCHIZOPHRENIA; VARIATION (GENETICS);

EID: 33845868222     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbl038     Document Type: Article

References (41)

1. Murrell T, Taylor W. The cutaneous reaction to niacinic acid (niacin)-furfuryl. Arch Dermatol. 1959;79:545-552.
2. Plummer NA, Hensby CN, Black AK, Greaves MW. Prostaglandin activity in sustained inflammation of human skin before and after aspirin. Clin Sci Mol Med. 1977;52:615-620.
3. Morrow J, Awad J, Oates J, Roberts L. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol. 1992;98:812-815.
4. Tavares H, Yacubian J, Talib LL, Barbosa NR, Gattaz WF. Increased phospholipase A2 activity in schizophrenia with absent response to niacin. Schizophr Res. 2003;61:1-6.
5. Smesny S, Rosburg T, Klemm S, et al. The influence of age and gender on niacin skin results - implications for the use as a biochemical marker in schizophrenia. J Psychiatr Res. 2004;38:537-543.
6. Messamore E. Relationship between the niacin skin flush response and essential fatty acids in schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 2003;69:413-419.
7. Morrow JD, Parsons WG, Roberts LJ. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins. 1989;38:263-274.
8. Horrobin DF. Schizophrenia: a biochemical disorder? Biomedicine. 1980;32:54-55.
9. Rybakowski J, Weterle R. Niacin test in schizophrenia and affective illness. Biol Psychiatry. 1991;29:834-836.
10. Glen AI, Cooper SJ, Rybakowski J, Vaddadi K, Brayshaw N, Horrobin DF. Membrane fatty acids, niacin flushing and clinical parameters. Prostaglandins Leukot Essent Fatty Acids. 1996;55:9-15.
11. Hudson CJ, Lin A, Cogan S, Cashman F, Warsh JJ. The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia? Biol Psychiatry. 1997;41:507-513.
12. Hudson C, Gotowiec A, Seeman M, Warsh J, Ross BM. Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia. Biol Psychiatry. 1999;46:401-405.
13. Nilsson BM, Hultman CM, Wiesel F-A. Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls. Prostaglandins Leukot Essent Fatty Acids. 2006;74:339-346.
14. Ward PE, Sutherland J, Glen EM, Glen AI. Niacin skin flush in schizophrenia: a preliminary report. Schizophr Res. 1998;29:269-274.
15. Shah SH, Vankar GK, Peet M, Ramchand CN. Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin. Schizophr Res. 2000;43:163-164.
16. Puri BK, Hirsch SR, Easton T, Richardson AJ. A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:49-52.
17. Puri BK, Easton T, Das I, Kidane L, Richardson AJ. The niacin skin flush test in schizophrenia: a replication study. Int J Clin Pract. 2001;55:368-370.
18. Messamore E, Hoffman WF, Janowsky A. The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study. Schizophr Res. 2003;62:251-258.
19. Ross BM, Hughes B, Turenne S, Seeman M, Warsh JJ. Reduced vasodilatory response to methynicotinate in schizophrenia as assessed by laser doppler flowmetry. Eur Neuropsychopharmacol. 2004;14:191-197.
20. Smesny S, Berger G, Rosburg T, et al. Potential use of the topical niacin skin test in early psychosis - a combined approach using optical reflection spectroscopy and a descriptive rating scale. J Psychiatr Res. 2003;37:237-247.
21. Puri BK, Singh I. Normal phospholipid-related signal transduction in autism. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:1405-1407.
22. Shah SH, Ramchand CN, Peet M. The niacin skin flush test: first-degree relatives show responses intermediate between patients and controls. Schizophr Res. 1999;36:314.
23. Waldo MC. Co-distribution of sensory gating and impaired niacin flush response in the parents of schizophrenics. Schizophr Res. 1999;40:49-53.
24. Falconer DS, Mackay TFC. Introduction to Quantitative Genetics. 4th ed. Harlow, UK: Longman; 1996.
25. James JW. Frequency in relatives for an all-or-none trait. Ann Hum Genet. 1971;35:47-49.
26. Risch N. Linkage strategies for genetically complex traits, I: multilocus models. Am J Hum Genet. 1990;46:222-228.
27. Nurnberger J Jr, Blehar M, Kaufmann C, et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry. 1994;51:849-859.
28. Chen WJ, Liu S-K, Chang C-J, Lien Y-J, Chang Y-H, Hwu H-G. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry. 1998;155:1214-1220.
29. Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry. 2004;61:310-317.
30. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R Stat Soc Ser B. 1995;57:289-300.
31. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependence. Ann Stat. 2001;29:1165-1188.
32. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198-1211.
33. Chen WJ, Chang C-H, Liu S-K, Hwang T-J, Hwu H-G. and collaborators from the Multidimensional Psychopathology Group Research Project. Sustained attention deficits in nonpsychotic relatives of schizophrenic patients: a recurrence risk ratio analysis. Biol Psychiatry. 2004;55:995-1000.
34. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1998.
35. Kleinbaum DG, Klein M. Logistic Regression - A Self-Learning Text. New York, NY: Springer-Verlag; 2002.
36. Chang C-J, Chen WJ, Liu S-K, et al. Morbidity risk of psychiatric disorders among the first degree relatives of schizophrenia patients in Taiwan. Schizophr Bull. 2002;28:379-392.
37. Tsuang MT, Tohen M. Textbook in Psychiatric Epidemiology. 2nd ed. Hoboken, NJ: John Wiley & Sons, Inc; 2002.
38. Smesny S, Riemann S, Riehemann S, Bellemann M, Sauer H. Quantitative measurement of induced skin reddening using optical reflection spectroscopy-methodology and clinical application. Biomed Tech. 2001;46:280-286.
39. Turenne SD, Seeman M, Ross BM. An animal model of nicotinic-acid-induced vasodilation: effect of haloperidol, caffeine and nicotine upon nicotinic acid response. Schizophr Res. 2001;50:191-197.
40. Berger G, McGorry P. The topical niacin flush test - a new assessment scale. World J Biol Psychiatry. 2001;2:134-135.
41. Eklund B, Kaijser L, Nowak J, Wennmalm A. Prostaglandins contribute to the vasodilation induced by nicotinic acid. Prostaglandins. 1979;17:821-830.